Selling, page-132

""I don’t believe the share price should be at these levels as there has been no bad news released to date""


""There seems to be no premium in share price to factor in any progress or success""

Both statement are spot and even in the most negative worldview you have admitted what is universal accepted. No bad news........ and many positive announcement not factored into the share price

Your only point is the market the market the market. Which has been shown for pre-revenue bio stocks total incapable of valuing a bio-stocks. Thus all it take is one disgruntled holder to suppress the shares and that is exactly what is happening. Because most retail investor only have their eye on the charts and not the trials.

Kazai is not even on the radar of the market. Some bio-journalist are not even aware that were are in the PK3I arena. That is a fact.

so hang your hat on the market all you want. But I wil make my investment decisions based on the fact the likes of Matt Dun has joined the dots and using GDC-0084 as a life line for his daughter. After he extensively researched the science. And thus far it has worked.

And as needle has just posted there are now recent study joining these inhibitors in combination with immunotherapy. The market does not diddle squat other than Paul Hopper wants the price lower and lower. And it is working.

If that give you a sense of superiority and bragging rights that you got it right........ we thank you.